24 June 2021
Hogan Lovells advises PerkinElmer, Inc. on the acquisition of SIRION BIOTECH GmbH
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Lutz Angerer Lead | Hogan Lovells | Partner | M&A | Munich |
| Guido Brockhausen Lead | Hogan Lovells | Counsel | M&A | Dusseldorf |
| Andreas Thun | Hogan Lovells | Counsel | M&A | Munich |
| Thomas Weber | Hogan Lovells | Counsel | M&A | Munich |
| Thomas Richter | Hogan Lovells | Senior associate | M&A | Munich |
| Stephanie Brüggemann | Hogan Lovells | Associate | M&A | Munich |
| Dr. Falk Loose | Hogan Lovells | Counsel | Tax | Munich |
| Jörg Schickert | Hogan Lovells | Partner | Commercial Regulatory | Munich |
| Dr Benjamin Goehl | Hogan Lovells | Associate | Commercial Regulatory | Munich |
| Falk Schöning | Hogan Lovells | Partner | Antitrust and Competition | Brussels |
| Stefan Kirwitzke | Hogan Lovells | Associate | Antitrust and Competition | Brussels |
| Dr Tim Joppich | Hogan Lovells | Partner | Employment | Dusseldorf |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- PerkinElmer, Inc.Buy-side
- Counterparties
- SIRION BIOTECH GmbH (Sell-side)